Xeris Biopharma Holdings, Inc. (XERS)
10.38
+0.20
(+1.91%)
USD |
NASDAQ |
Oct 09, 12:44
Xeris Biopharma Holdings Price : 10.38 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 10.10 | 10.35 | 10.00 | 10.19 | 1.979M |
| Oct 07, 2026 | 10.00 | 10.27 | 9.91 | 10.11 | 2.221M |
| Oct 06, 2026 | 10.23 | 10.32 | 9.90 | 10.07 | 2.404M |
| Oct 05, 2026 | 9.15 | 10.24 | 9.12 | 10.13 | 4.665M |
| Oct 02, 2026 | 9.34 | 9.34 | 9.035 | 9.08 | 1.804M |
| Oct 01, 2026 | 9.52 | 9.69 | 9.175 | 9.25 | 3.591M |
| Sep 30, 2026 | 9.97 | 10.07 | 9.545 | 9.56 | 3.753M |
| Sep 29, 2026 | 9.77 | 11.33 | 9.50 | 9.98 | 19.31M |
| Sep 28, 2026 | 9.05 | 10.00 | 9.00 | 9.83 | 4.463M |
| Sep 25, 2026 | 8.99 | 9.15 | 8.850 | 9.10 | 1.547M |
| Sep 24, 2026 | 8.65 | 8.995 | 8.56 | 8.95 | 1.360M |
| Sep 23, 2026 | 8.74 | 9.20 | 8.455 | 8.66 | 2.043M |
| Sep 22, 2026 | 8.90 | 8.97 | 8.64 | 8.73 | 1.689M |
| Sep 21, 2026 | 8.28 | 8.81 | 8.16 | 8.80 | 3.231M |
| Sep 18, 2026 | 8.10 | 8.25 | 7.93 | 8.20 | 4.709M |
| Sep 17, 2026 | 7.685 | 8.18 | 7.685 | 8.16 | 2.341M |
| Sep 16, 2026 | 7.50 | 7.92 | 7.50 | 7.78 | 2.035M |
| Sep 15, 2026 | 7.57 | 7.58 | 7.41 | 7.49 | 1.181M |
| Sep 14, 2026 | 7.595 | 7.685 | 7.52 | 7.57 | 2.006M |
| Sep 11, 2026 | 7.89 | 7.89 | 7.40 | 7.45 | 2.403M |
| Sep 10, 2026 | 7.80 | 7.99 | 7.63 | 7.67 | 1.955M |
| Sep 09, 2026 | 8.43 | 8.605 | 7.64 | 7.71 | 2.816M |
| Sep 08, 2026 | 8.39 | 8.515 | 8.22 | 8.48 | 1.355M |
| Sep 04, 2026 | 8.50 | 8.585 | 8.38 | 8.53 | 1.031M |
| Sep 03, 2026 | 8.64 | 8.775 | 8.415 | 8.59 | 1.598M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zevra Therapeutics, Inc. | 11.39 |
| Aclaris Therapeutics, Inc. | 3.91 |
| ANI Pharmaceuticals, Inc. | 73.62 |
| Corcept Therapeutics, Inc. | 121.24 |
| Veru, Inc. | 2.46 |
Price Related Metrics
| PS Ratio | 5.481 |
| Price to Free Cash Flow | 33.03 |
| Earnings Yield | -0.99% |
| Market Cap | 1.803B |
| Operating PE Ratio | 50.24 |
| Normalized PE Ratio | 465.70 |